Panagiota Giannoulia

Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistance

Ilaria Iacobucci, Annalisa Lonetti, Francesca Messa et al. · Blood · 2008 · 109 citations · Full text

Medicine, Hematology, Oncology +16

Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience

Maria K. Angelopoulou, Theodoros P. Vassilakopoulos, Ioannis Batsis et al. · Hematological Oncology · 2017 · 20 citations · Full text

Medicine, Hematology, Oncology +14

Philadelphia Chromosome-Positive Leukemia Patients Who Harbor Imatinib-Resistant Mutations Have a Higher Likelihood of Developing Additional Mutations Associated with Resistance to Novel Tyrosine Kinase Inhibitors.

Simona Soverini, Alessandra Gnani, Sabrina Colarossi et al. · Blood · 2007 · 10 citations

Medicine, Genetics, Oncology +17